L
Laurence Collette
Researcher at European Organisation for Research and Treatment of Cancer
Publications - 281
Citations - 37642
Laurence Collette is an academic researcher from European Organisation for Research and Treatment of Cancer. The author has contributed to research in topics: Prostate cancer & Cancer. The author has an hindex of 78, co-authored 276 publications receiving 33811 citations. Previous affiliations of Laurence Collette include VU University Amsterdam & Université catholique de Louvain.
Papers
More filters
Journal Article
Profylactische schedelbestraling bij patiënten met uitgebreid kleincellig longcarcinoom dat reageert op chemotherapie : minder symptomatische hersenmetastasen en betere overleving
Berend J. Slotman,Corinne Faivre-Finn,G.W.P.M. Kramer,E.M. Rankin,M. Snee,Matthew Hatton,P E Postmus,Laurence Collette,Elena Musat,Suresh Senan +9 more
TL;DR: PCI significantly reduced the incidence of symptomatic brain metastases and prolonged both disease-free and overall survival and should be part of standard care in SCLC patients who respond to chemotherapy.
Journal ArticleDOI
P126 Including literature data in individual patient data meta-analyses for time-to-event endpoints
Journal ArticleDOI
Selection bias is not a good reason for advising more than 5 years of adjuvant hormonal therapy for all patients with locally advanced prostate cancer treated with radiotherapy
Laurence Collette,Urs E. Studer +1 more
TL;DR: It is concluded that patients who received androgendeprivation treatment for more than 5 years had improved overall, disease-specific, and progression-free survival compared with patients who underwent shorter hormonal therapy duration (HTD).
Journal ArticleDOI
A unique research infrastructure from the European Organisation for Research and Treatment of Cancer (EORTC) to optimize long-term follow up of patients-the YOU (Your Outcome Update) protocol: Rationale, scope, design and research opportunities
TL;DR: The current paper aims to illustrate the rationale, scope, design and research perspectives of the YOU protocol (Your Outcome Updates), which was launched via a research infrastructure named the EORTC (EORTC) last year.
Journal ArticleDOI
Recruiting long-term survivors of European Organisation for Research and Treatment of Cancer phase III clinical trials into quality of life studies: Challenges and opportunities
Marieke van Leeuwen,Fabio Efficace,Sophie D. Fosså,Michel Bolla,Ugo De Giorgi,Ronald de Wit,Bernhard Holzner,Lonneke V. van de Poll-Franse,Hendrik Van Poppel,Jeffrey D. White,Laurence Collette,Susanne Osanto,Neil K. Aaronson +12 more
TL;DR: HRQoL research among long-term survivors of EORTC phase III clinical trials is possible, but the process of ethical approval and data collection is a lengthy one.